Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder

This study has been completed.
Sponsor:
Information provided by:
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00628979
First received: February 25, 2008
Last updated: July 1, 2009
Last verified: July 2009
  Purpose

The purpose of this study is to understand some of the reasons why recently deployed veterans decline psychosocial treatment options for panic disorder and to test a brief weekend treatment for panic attacks.


Condition Intervention
Panic Disorder
Behavioral: CBT

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Addressing Help-Seeking Barriers in Developing an Intensive Treatment for Veterans With Panic Disorder

Resource links provided by NLM:


Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • Qualitative data regarding treatment seeking barriers [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Panic attack frequency and severity; treatment acceptability [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 23
Study Start Date: March 2008
Study Completion Date: July 2009
Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1
CBT
Behavioral: CBT
cognitive- behavioral treatment for panic disorder.
Other Name: CBT

Detailed Description:

The population of interest for this program includes men and women returning from deployment in Iraq or Afghanistan who are seen in the TRP at the MEDVAMC. The study consists of two parts: PART 1 involves a qualitative investigation of treatment-seeking barriers specific to persons who refuse standard treatments and PART 2 is a pilot intervention to treat panic symptoms in service members who have co-existing PTSD symptoms. PART 1 will include approximately 15 individuals who will be interviewed by a member of the study staff. Patients will be interviewed individually following a semi-structured questionnaire designed to help identify treatment-seeking barriers. PART 2 will include 8 individuals who will be enrolled in an open-trial of a two-day intensive cognitive-behavioral treatment for panic disorder, which will occur over the weekend. No participants will be assigned to a control condition. All activities related to this project including the interviews and intervention will be delivered in either the TRP at the MEDVAMC or at the Houston Center for Quality of Care and Utilization Studies (HCQCUS), a nearby facility.

  Eligibility

Ages Eligible for Study:   18 Years to 74 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Veterans;
  2. age 18-74;
  3. current diagnosis of panic disorder;
  4. PTSD symptoms that either meet full diagnostic criteria from the Diagnostic and Statistical Manual-Fourth Edition (DSM-IV) or are at a sub-clinical level. Sub-clinical PTSD is defined as patients who meet either PTSD criteria B and C or B and D, but fail to meet all three;
  5. panic disorder and PTSD present for at least 1 month;
  6. PART 1 only: patients who are clinically eligible to participate in the study and refuse standard psychosocial treatments (e.g., 12 weeks of cognitive behavioral therapy) for panic disorder.

Exclusion Criteria:

  1. Current substance dependence;
  2. diagnosed with bipolar disorder or psychosis;
  3. current suicidal/homicidal ideation and intent;
  4. severe depression (precluding participation in a research study);
  5. panic attacks related only to a diagnosis of a specific phobia;
  6. medical conditions mimicing anxiety (e.g., mitral valve prolapse);
  7. PART 1 only: patients who are clinically eligible for the study and are willing to engage in a minimum of 12 weeks of psychosocial treatment for panic disorder.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00628979

Locations
United States, Texas
Michael E. DeBakey VA Medical Center (152)
Houston, Texas, United States, 77030
Sponsors and Collaborators
Investigators
Principal Investigator: Ellen Teng, PhD Michael E. DeBakey VA Medical Center (152)
  More Information

No publications provided

Responsible Party: Teng, Ellen - Principal Investigator, Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00628979     History of Changes
Other Study ID Numbers: MIRECC004
Study First Received: February 25, 2008
Last Updated: July 1, 2009
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Panic Disorder
Disease
Anxiety Disorders
Mental Disorders
Pathologic Processes

ClinicalTrials.gov processed this record on September 16, 2014